Related Experiment Video
Updated: Dec 29, 2025

Constitutive and Inducible Systems for Genetic In Vivo Modification of Mouse Hepatocytes Using Hydrodynamic Tail Vein Injection
Published on: February 2, 2018
Factor VIII: Perspectives on Immunogenicity and Tolerogenic Strategies
David W Scott1, Kathleen P Pratt1
1Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, United States.
Therapeutic treatment with Factor VIII (FVIII) can trigger an antibody response that blocks its function. This review explores factors causing FVIII immunogenicity and strategies to overcome it.
Area of Science:
- Immunology
- Hematology
- Pharmacology
Background:
- Hemophilia A treatment involves Factor VIII (FVIII) replacement therapy.
- FVIII inhibitors (antibodies) are a significant complication, hindering treatment efficacy.
- Understanding inhibitor development is crucial for improving patient outcomes.
Purpose of the Study:
- To review the factors contributing to FVIII immunogenicity.
- To discuss strategies for overcoming FVIII antibody responses.
- To provide insights into managing inhibitor development in hemophilia.
Main Methods:
- Literature review of studies on FVIII immunogenicity.
- Analysis of factors influencing antibody formation against FVIII.
- Synthesis of current and emerging strategies to mitigate FVIII inhibitor risk.
Main Results:
- Immunogenicity is influenced by FVIII product characteristics, patient genetics, and treatment protocols.
- Various strategies, including immune tolerance induction and modified FVIII products, are being explored.
- Early identification and management of risk factors are key.
Conclusions:
- FVIII immunogenicity remains a major challenge in hemophilia care.
- A multi-faceted approach considering product, patient, and treatment factors is necessary.
- Further research is needed to develop more effective methods to prevent or manage FVIII inhibitors.
Related Concept Videos
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Microorganisms in Medicine and Therapeutics
Special Features of Adaptive Immunity
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
Factors Affecting Drug Response: Overview
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...
Tumor Immunotherapy

